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Edited by Gianni CesareniAbstract The cadherin superfamily protein Fat1 is known to
interact with the EVH1 domain of mammalian Ena/VASP. Here
we demonstrate that: (i) the scaﬀolding proteins Homer-3 and
Homer-1 also interact with the EVH1 binding site of hFat1
in vitro, and (ii) binding of Homer-3 and Mena to hFat1 is mutu-
ally competitive. Endogenous Fat1 binds to immobilised Homer-
3 and endogenous Homer-3 binds to immobilised Fat1. Both,
endogenous and over-expressed Fat1 exhibit co-localisation with
Homer-3 in cellular protrusions and at the plasma membrane of
HeLa cells. As Homer proteins and Fat1 have been both linked
to psychic disorders, their interaction may be of patho-physiolog-
ical importance.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The giant human cadherin family protein human Fat1
(hFat1) comprises an extracellular domain of 4162 amino
acids, a 21 amino acid transmembrane domain, and an intra-
cellular domain of 386 amino acids. Mammalian Fat1 protein
is well expressed in proliferating epithelial tissues, especially
during development, and is assumed to be a fundamental com-
ponent in the initial step of cell–cell contact formation of glo-
merular podocytes. Deletion of Fat1 in mice is lethal due to
malformation of glomeruli and failure of renal function. In
addition, frequent defects in the development of frontal brain
(holoprosencephalia) and eyes (cyclopia and anophthalmia)
were observed. Fat proteins and other protocadherins are also
regarded as potential tumour suppressor proteins (see [1] for
review of the literature).
Localisation of the transmembrane form of Fat1 has been
described at lamellipodial edges and ﬁlopodial tips of cultured
cell lines [1]. The protein appears to be involved in the dynamic
regulation of the actin cytoskeleton by binding to mammalian
Ena (Mena) via its class I EVH1 binding sequence 4437FPPPP
[1,2] (cf. Scheme of hFat1 in Fig. 1). The Ena/VASP proteinAbbreviations: EGFP, enhanced green ﬂuorescent protein; GST, glut-
athion S-transferase; hFat1, human Fat1; Mena, mammalian Ena/
VASP
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doi:10.1016/j.febslet.2006.08.079family regulates the actin cytoskeleton assembly by antagonis-
ing capping proteins and by enhancing the dissociation of
branched junctions of actin ﬁlaments. We [3] have provided
evidence for proteolytic processing of transmembrane forms
of hFat1 followed by translocation of the released intracellular
domain into the nucleus.
Here, we provide in vitro and in situ evidence for strong
binding between the intracellular domain of hFat1 and Homer
family scaﬀolding proteins. Homer proteins form signalling
complexes with a number of diﬀerent proteins acting at key
points in critical signalling pathways, such as metabotropic
glutamate receptors, inositol trisphosphate-dependent Ca2+
channels, transient receptor potential ion channels, small
GTPases, cytoskeletal proteins, and transcription factors (re-
viewed by [4]). Homer proteins facilitate the accumulation of
actin at synapses and modulate dendritic spine function in
the nervous system. Homer proteins are involved in cocaine-in-
duced neurological eﬀects and in the pathogenesis of schizo-
phrenic disorders (reviewed by [5]). Homer proteins are also
widely expressed in non-neuronal tissues [4]. Homer-3 has been
recently shown to be translocated to the nucleus and to regu-
late activation of serum response element upon stimulation
of Jurkat cells by anti-CD3 and CD28 [7]. Remarkably, the
genomic locus encoding the EVH1 binding regions of hFat1
has been recently identiﬁed to confer susceptibility to familial
bipolar disorder [6]. Detailed knowledge about interaction be-
tween Homer proteins and hFat1 may provide a link for
understanding of physiological and pathologic events.2. Materials and methods
2.1. DNA constructs
The intracellular domain of hFat1 (hFat1-c, bp 12613–13773), full
length Homer proteins, and Mena were expressed in Escherichia coli
in fusion with glutathion S-transferase (GST) (pGEX-4T1) or as
hFat1-c-His6 (pET-29b). Point mutations were introduced by PCR.
Vectors for transfections of cells were pEGFP-N3, with hFat1-c or
trans-membrane (D1–3683) hFat1 (termed hFat1-TEX) as inserts, or
pCDNA3 (HA constructs). All constructs were controlled by DNA
sequencing (SeqLab, Go¨ttingen, Germany).
2.2. Cell culture and immunocytochemistry
HeLa cells were cultured in DMEM and PAM-212 in RPMI, both
complemented with 10% FCS (Gibco), 2 mM L-glutamine, 1 U/ml pen-
icillin, 100 lg/ml streptomycin. FuGene 6 (Roche) was used for trans-
fections. A standard protocol was used for immuno-cytochemistry.
Monospeciﬁc polyclonal anti-hFat1-c was obtained by treatment with
immobilized NEDD5-His6 expressed in E. coli followed by aﬃnity
puriﬁcation with the antigen. Speciﬁcity of the antiserum was
controlled by knock-down of endogenous protein by short hair-pin
RNA (not shown).blished by Elsevier B.V. All rights reserved.
Fig. 1. Schematic representation of hFat1 structure and the location of EVH1 binding sites. The putative transmembrane domain corresponds to
amino acids 4163–4183.
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Puriﬁed hFat1-c-His6 or BSA (6 mg each) were covalently coupled
to NHS-HP Sepharose (1 ml HiTrap column, Amersham). The col-
umns were equilibrated with 10 ml buﬀer A (20 mM TEA, pH 7.4,
50 mM NaCl, 1 mM EDTA, 0.5%-NP40) plus 10% glycerol. Mouse
brains (3 g) were powdered in liquid N2, homogenised in 20 ml buﬀer
A (containing aprotinin 1 lg/ml, pepstatin 1 lg/ml, PMSF 1 mM) and
centrifuged (100000 · g, 1 h). Equal volumes of the supernatant (plus
10% glycerol) were applied to the aﬃnity columns (ﬂow 0.5 ml/min).
Washing and elution was accomplished as follows: 30 ml buﬀer A
(without NP-40), 2 ml each of buﬀer A containing NaCl of increasing
concentrations (200, 300, 500, 800, and 2000 mM), and ultimately 6 M
Urea. Protein was precipitated from the 2 ml fractions (methanol/chlo-
roform method), suspended in 100–140 ll Laemmli sample buﬀer, sep-
arated by SDS–PAGE on 3–15% PAA gradient gels, and stained with
Coomassie Brilliant Blue. Direct binding was checked by binding of
[32P] labelled hFat1 (using protein kinase A) following a standard
‘‘Far-Western’’ protocol.
2.4. MALDI-TOF
Following a standard protocol, the protein bands of interest were
cut from gels, digested with trypsin (sequencing grade trypsin, Prome-
ga). The eluted peptides were desalted by Zip-Tip-C18 (Millipore).
Mass spectra were acquired by linear MALDI-TOF (Bruker Dalto-
nik). ProFound and Mascot software was used for database search.
2.5. Extraction and pull-down of native proteins
Two 10 cm dishes PAM-212 (90% conﬂuence) were lysed in 0.5 ml
TNN buﬀer (50 mM Tris–HCl, pH 7.4, 300 mM NaCl, 1% NP40).
The supernatant was diluted to 2 ml with T25N50 buﬀer (25 mM
Tris–HCl, 50 mM NaCl) and incubated with 50 ll GSH-Sepharose
coupled recombinant protein (5 h). The beads were suspended in
40 ll Laemmli buﬀer after 5 washes with TNN. Fat1 was probed with
the antiserum described in 2.2, Homer with monoclonal Ab sc-17842
(Santa Cruz).
2.6. Binding assays
Binding of hFat1-c-His6 to Homer proteins and Mena was quanti-
tatively assessed by a TMB-coupled ELISA procedure employing
monoclonal anti-penta-His (Quiagen, Cat. No. 34660) and peroxi-
dase-coupled anti-mouse IgG (Calbiochem) as primary and secondary
antibodies. Plates were coated with Homer-3-GST, Mena-GST or
GST, respectively (1 lg/well in 50 mMNa-bicarbonate, pH 9), blocked
with 5% milk powder in PBS (1 h), and incubated with hFat1-c-His6
proteins (1 lg/well in 1% milk-PBS, 2 h). The detection procedure fol-
lowed the standard protocol.Fig. 2. Identiﬁcation of binding partners of hFat1-c. (A) Separation of
proteins from mouse brains eluted from immobilised hFat1-c-His6 or
immobilised bovine serum albumin by 6 M urea (see Section 2). The
positions of Homer-3, Homer-1 and of kinesin heavy (Kif5c) and light
(KLC1, KLC2) chains are indicated. (B) Binding of [32P] labelled
hFat1-c-His6 to the urea fractions after separation by SDS–PAGE and
blotting to nitrocellulose.3. Results and discussion
3.1. Identiﬁcation of interaction partners of the intracellular
domain of hFat1
This study aimed at the detection of intracellular interaction
partners of hFat1 in addition to previously described Mena
[1,2]. Human Fat1 contains several potential binding motifs,
including proline-rich motifs and a putative C-terminal PDZdomain binding site. This PDZ-binding site was masked by
the fusion of the His6-tag in order to exclude the interaction
of PDZ proteins from this study. The puriﬁed intracellular do-
main of hFat1 (hFat1-c-His6), as expressed in E. coli, was
covalently coupled to NHS-activated Sepharose and treated
with mouse brain extracts (see Section 2). SDS–PAGE repro-
ducibly allowed detection of ﬁve prominent protein bands in
fractions eluted from immobilised hFat1-c by 6 M urea
(Fig. 2A, see Section 2). Characterisation by MALDI-TOF
and database search identiﬁed two of these proteins as the
‘‘scaﬀolding’’ proteins Homer-1 and Homer-3. The other
bands were the kinesin subunits Kif5C, KLC2, and KLC1.
More than 40% of the sequences of these proteins were covered
by the MALDI-TOF data in three independent experiments.
(Note: Mena was present in the 0.8 M NaCl fraction but ab-
sent from the urea fraction). The Homer-1 and Homer-3 bands
(and also the Kif5C band) reacted with [32P] labelled hFat1-c-
His6 after blotting to nitrocellulose (Fig. 2B). Although addi-
tional experiments conﬁrmed the binding of the kinesin heavy
chain Kif5C to hFat1-c (data not shown), this report will con-
centrate on the interactions between hFat1 and Homer pro-
teins.
3.2. Conﬁrmation of direct binding between hFat1-c and Homer
proteins
The interactions between hFat1-c and Homer proteins were
consistently conﬁrmed by in vitro pull-down experiments as
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hFat-1c bind to each other regardless of which of the proteins
is immobilised or in the soluble phase. This conﬁrms that bind-
ing of the partners is direct and not mediated by additional
components. The experiments also suggest that binding of
Homer-3 to hFat1-c is stronger than that of Homer-1. The
interaction between Homer-3 and hFat1-c was conﬁrmed by
quantitative yeast 2-hybrid assays (data not shown), and by
quantitative binding assays (see below). The corresponding
experiments with the closely related Homer-1 also suggested
weaker interactions compared to those with Homer-3, albeit
Kd values have not been determined so far.
The pull-down of an endogenous full-length Homer protein
from PAM-212 cells by the immobilised intracellular domain
of hFat1 is depicted by the single band shown in Fig. 4A.
The monoclonal antibody used in the experiment recognises
an epitope in the highly conserved N-terminal EVH1 domain
of Homer proteins and does not distinguish between the vari-
ous isoforms nor between human and mouse proteins. Immo-
bilised Homer-3 was also able to pull down endogenous hFat1
from extracts of PAM-212 cells (derived from mouse keratino-
cytes containing high amounts of endogenous Fat1 with >96%
amino acids in the intracellular domain identical to the human
protein) as shown in Fig. 4B. The Fat1 protein was clearly en-
riched by the procedure. The same results were obtained with
primary cultures of mouse renal podocytes (data not shown).Fig. 3. Conﬁrmation of direct binding between hFat1-c and Homer
proteins. Puriﬁed recombinant hFat1-c-His6 (2 lg) was incubated with
2 lg GST-Homer-1, GST-Homer-3, or GST (all coupled to GSH-
Sepharose) or with GSH-Sepharose. The beads were washed exten-
sively, suspended in Laemmli sample buﬀer, separated by SDS–PAGE
(10%), and probed for hFat1-c-His6.
Fig. 4. Binding of recombinant hFat1-c and Homer-3 to the endogenous part
Homer protein to immobilised recombinant hFat1-c. (Separation by 10%
recombinant Homer-3 (Separation by 4.5% SDS–PAGE). The input correspAlthough the Mr of the single band detected by the antiserum
raised against the intracellular domain of hFat1 (see Section 2)
cannot be evaluated exactly due to the lack of marker proteins
of appropriate size, the protein migrates as expected for the
500 kDa full-length Fat1.
These experiments demonstrate mutual interactions of puri-
ﬁed hFat1 and Homer-3 with the endogenous partner and lar-
gely rule out inﬂuences of potential misfolding of the
recombinant binding partner. Although direct binding be-
tween hFat1 and Homer was conﬁrmed by in vitro experi-
ments, additional cellular components may have been pulled-
down from cell extracts.
3.3. Co-localisation of hFat1 and Homer
Co-localisation of over-expressed hFat1 and Homer proteins
in HeLa cells is demonstrated in Fig. 5A and B. Fig. 5A shows
HeLa cells co-transfected with vectors expressing HA-tagged
human Homer-3 and a transmembrane construct of hFat1
(hFat1-TEX-EGFP, see Section 2). Over-expression of the
hFat1 construct (either alone or in combination with Homer
proteins) in several cell lines, including HeLa, enhances the
formation of cellular protrusions. The over-expressed hFat1
construct is predominantly located at the tips of these protru-
sions (Fig. 5A, left). Most of Homer-3 is diﬀusely distributed in
the cytoplasm and at the plasma membrane (Fig. 5A, middle).
Nevertheless, a fraction of Homer-3 shows co-localisation with
hFat1 at the tips of the protrusions (merged image, Fig. 5A,
right). Homer-1 exhibited the same localisation pattern as
Homer-3 (not shown). Fig. 5B represents images of HeLa cells
expressing Homer-3 in C-terminal fusion with ECFP (middle).
Endogenous hFat1 was stained with a mono-speciﬁc poly-
clonal antibody (see Section 2) raised against the cytoplasmic
domain (left). The merged image (right) shows co-localisation
of endogenous hFat1 with expressed Homer-3 not only at the
plasma membrane (arrows), but also at distinct spots in the
perinuclear region. The bottom row of Fig. 5B shows the co-
localisation (right, merged image) of endogenous hFat1 (left)
and Homer-3 (middle) in a cellular protrusion.
Co-localisation of hFat1 and Homer proteins in cells was
corroborated by recruitment experiments similar to those pre-
viously shown by [2] for hFat1 and Mena (data not shown).
3.4. Mapping of the hFat1 site interacting with Homer proteins
Homer proteins contain an EVH1 domain that interact with
class II EVH1 binding sites formed by the sequence PPxxF [8].ner proteins extracted from PAM-212 cells. (A) Binding of endogenous
SDS–PAGE). (B) Binding of endogenous hFat1 to immobilised
onds to 5% of the total extract.
Fig. 5. Co-localisation of hFat1 and Homer proteins in HeLa cells. (A) A truncated transmembrane form of hFat1 in C-terminal fusion with EGFP
(Fat1-TEX-EGFP) and haemaglutinin-tagged Homer 3 (Homer-3-HA) were co-expressed. Left: EGFP ﬂuorescence; middle: HA-immunoﬂuores-
cence (Alexa 594); right: merged images plus nuclear staining. The arrows indicate typical spots of co-localisation in a cellular protrusion and at the
plasma membrane. (B) Colocalisation of endogenous hFat1 (left, stained with a monospeciﬁc antiserum, see Section 2) and Homer-3-fused to ECFP
(middle). Right: Merged images plus nuclear staining. The arrows point to the plasma membrane. Lower panel: co-localisation of endogenous hFat1
and expressed Homer-3 in a cellular process.
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candidate interaction site for Homer proteins. A quantitative
ELISA-based in vitro interaction assay was designed to study
the validity of this assumption. Mena, interacting with the
class I EVH1 binding site 4437FPPPP [2] (cf. Fig. 1) was used
for comparison. Puriﬁed Homer (or Mena) GST-fusion pro-
teins were immobilised on ELISA plates and then incubated
with puriﬁed wild type or mutant hFat1-c-His6. Subsequently
an ELISA-based quantiﬁcation was done using monoclonal
anti-penta-His antibody. The results of these assays are de-
picted in Fig. 6 for the binding of hFat1-c-His6 by Homer-3
(Fig. 6A) and Mena (Fig. 6B). The data were compiled from
ﬁve independent experiments (quadruplicate determinations),
each performed with diﬀerent lots of recombinant proteins in
order to control the potential variability in the folding of the
recombinant proteins. The binding of hFat1-c to Homer-1
was weaker than to Homer-3 (data not shown), however, the
binding of the hFat1-c mutants exhibited the same qualitative
pattern. Deletion of the complete canonical EVH1 binding re-
gions of hFat1 (D4437–4444) almost abolished binding of
both, Homer-3 and Mena. Point mutations of phenylalanine
or proline residues in the hFat1(4437–4444) region attenuated
binding of Homer-3 as well as binding of Mena, although
quantitative diﬀerences between the point mutations were no-
ticed. Almost 90% of the binding of Homer-3 and Mena was
abrogated by the P4440D mutation. This corresponds to the
mutation analysis of an oligopeptide binding to a class I
EVH1 domain [9] and is also expected from the experimentsperformed with a peptide binding to a class II EVH1 domain
[10]. Compared to binding by the wild type protein, binding
of Homer-3 to the P4441A mutant is reduced by 45% while
binding of Mena is reduced by less than 30%. On the other
hand, the binding of Mena is more strongly aﬀected than bind-
ing of Homer-3 by the P4438A mutation. Furthermore, muta-
tions of the phenylalanines present in the canonical class I
(F4437) and class II (F4444) EVH1 binding sites aﬀect binding
of both Homer-3 and Mena. However, the eﬀect of the
F4437V mutation was consistently greater with regard to the
binding of Mena while the F4444V mutation more eﬃciently
impaired binding of Homer-3.
The data depicted in Fig. 6 not only suggest that Mena and
Homer-3 bind to EVH1 binding sites in the 4437–4444 region
of hFat1, but also that their binding sites are overlapping.
Stronger binding of Mena (as compared to Homer-3) to the re-
gion preceding P4441 and stronger binding of Homer-3 to the
region following P4440 correspond with the observations that
the EVH1 domains of Homer proteins bind class II sites [8],
whereas Mena includes a class I EVH1 binding domain [1,2].
In hFat1, the class I and class II binding sites overlap at
P4440 and P4441. The data presented in Fig. 6 show an inﬂuence
of mutations in positions preceding P4440 on binding of
Homer-3 and of mutations following P4441 on binding of
Mena. One possible explanation could be that the canonical
deﬁnition of class I and class II EVH1 binding sites is based
on studies with oligopeptides and may not fully reﬂect the ste-
ric situation of EVH1 binding sites in a protein like hFat1. On
A B
Fig. 6. In vitro binding of hFat1-c-His6 to Homer-3-GST (A) and Mena-GST (B) determined by a direct ELISA. Homer-3-GST (A) or Mena-GST
(B) (1 lg each) were coated to ELISA wells and incubated with recombinant wild type or mutant hFat1-c-His6 (1 lg) as indicated in the ﬁgures after
blocking the plates (see Section 2 for details). DEVH-BM is hFat1-c(D4437–4444). The signal obtained for the binding of wt hFat1-c to 1 lg Mena
was about 40% of that observed for 1 lg Homer-3. Five independent series of experiments with freshly puriﬁed lots of recombinant proteins were
performed. The data (n = 4) were standardized with the signal obtained for wt hFat1 within a series of experiments (standard deviations <10% of
mean). The data given in the ﬁgures represent the means ± S.D. of the accumulated experiments.
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into account potential structural rearrangements in the protein
that are likely to be induced by mutations in general, and in
particular by the mutation of proline residues. Since binding
is conserved to a signiﬁcant extent in most mutants (except
the D4437-4444 deletion and the P4440D mutation), the muta-
tions evidently did not completely destroy the architecture of
the interaction site.
3.5. Homer and Mena compete for binding sites on hFat1
The results of the binding and mutation assays suggest an
overlap of the hFat1 sites binding to Homer-3 and Mena. This
would imply that Homer-3 and Mena should mutually inhibit
the binding of the other protein to hFat1. This was tested by
the experiments depicted in Fig. 7. They show binding of wild
type hFat1-c to immobilised Mena in the presence of increas-
ing concentrations of Homer-3 (Fig. 7A), or to immobilised
Homer-3 in the presence of increasing concentrations of Mena
(Fig. 7B), respectively. In both series of experiments, binding
was greatly inhibited when the second EVH1 domain proteinA B
Fig. 7. (A) Inhibition of binding of 1 lg wt hFat1-c-His6 to 1 lg Mena-G
Inhibition of binding of 1 lg wt hFat1-c-His6 to 1 lg Homer-3-GST by pre-in
GST (mean ± S.D., n = 4).was present. This is in agreement with the proposed overlap
of Mena and Homer binding sites in hFat1. Given the impor-
tant, albeit diﬀerent, roles of Ena/VASP and Homer protein
families in cells, binding of these proteins to hFat1 is poten-
tially regulated by presently unknown mechanisms.
Canonical class I and class II EVH1 binding sites are only
contained in the intracellular domains of vertebrate Fat1 pro-
teins. They are apparently absent from non-mammalian homo-
logues and from mammalian Fat2 and FatJ proteins.
Mammalian Fat3 contains a sequence with similarity to a class
II EVH1 binding site. A typical class II (but not class I) EVH1
binding site is present in the Fat1 homologue from zebraﬁsh .
Notably, no putative EVH1 binding sequence is present in Fat
family proteins from Drosophila. This may indicate evolution-
dependent variations in the functions of the intracellular
domains of Fat proteins.
The N-terminal EVH1 domains of all isoforms of Homer
proteins are highly homologous and all amino acids in direct
contact with the class II binding sites are identical. Therefore,
only minor variations in the binding properties are expected.ST by increasing amounts of Homer-GST (mean ± S.D., n = 8). (B)
cubation with increasing amounts (indicated by the abscissa) of Mena-
5300 D. Schreiner et al. / FEBS Letters 580 (2006) 5295–5300Homer-1 and Homer-3 genes are expressed in many tissues,
but cell-speciﬁc expression in brain has attracted special atten-
tion [11,12]. In this context, our observation of strong binding
to Fat1, a protein involved in brain development and ex-
pressed in some regions of adult brain, may be of functional
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